The U.S. International Trade Commission (ITC) has issued an order that could potentially bar Apple from importing its Apple Watches. The decision comes after the ITC found that the devices violate the patent rights of medical technology company Masimo.
Specifically, Apple's use of light-based technology for reading blood-oxygen levels infringes on Masimo's rights, according to Bloomberg.
Presidential Review and Possible Appeals Await the Decision
Reuters reported that while the ITC ruling will not have an immediate effect, it now faces review by President Joe Biden's administration. The administration will have 60 days to determine whether to veto the import ban based on policy concerns before it goes into effect.
It is worth noting that presidents rarely veto bans in these circumstances. Additionally, Apple can appeal the ban to the U.S. Court of Appeals for the Federal Circuit after the review period ends.
Masimo Chief Executive Officer Joe Kiani has expressed satisfaction with the ruling, stating that it "sends a powerful message that even the world's largest company is not above the law."
The ITC decision, however, did not specify which models of Apple Watches would be affected by the ban. Masimo's original complaint mentioned that the 2020 Apple Watch Series 6, which introduced blood-oxygen monitoring capabilities, infringed on its patents.
Intellectual Property Fight Between Apple and Masimo
The dispute between Apple and Masimo spans several jurisdictions and began with Masimo accusing Apple of stealing its technology and incorporating it into multiple Apple Watch models. In May, a jury trial on Masimo's allegations in a California federal court ended with a mistrial.
In addition to the ITC case, Apple has separately sued Masimo for patent infringement in federal court in Delaware. Apple claims that Masimo's legal actions are a tactical move to clear the path for its competing smartwatch.
Apple is also involved in a patent dispute with medical technology company AliveCor, which has led to an ITC-issued ban on Apple Watch imports. However, the ban is currently on hold during related proceedings concerning the validity of AliveCor's patents.
According to a company report, Apple's wearables, home, and accessory business, including the Apple Watch, AirPods earbuds, and other products, produced an impressive revenue of $8.28 billion in the third quarter of 2023.
Photo: Sophia Stark/Unsplash


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



